周四夜盘交易中，Absci Corporation（股票代码：ABSI）股价大幅上涨5.30%，引发市场关注。这一涨幅出现在分析师下调目标价的背景下，显示出投资者对该公司前景的乐观情绪。
根据最新消息，投资银行Needham将Absci的目标价从8美元下调至7美元。通常情况下，分析师下调目标价会对股价产生负面影响，但Absci股价的强劲表现似乎与这一预期相悖。这可能表明，尽管面临短期挑战，投资者仍看好公司的长期发展前景。
Absci Corporation是一家生物技术公司，专注于利用人工智能和合成生物学来加速蛋白质药物的发现和生产。公司的创新平台旨在改革传统的药物开发流程，提高效率并降低成本。值得注意的是，尽管Needham下调了目标价，但7美元的新目标价仍然高于当前交易价格，这可能是支撑股价上涨的一个因素。投资者似乎更关注公司的基本面和长期潜力，而不仅仅是短期的价格目标调整。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.